author-photo

Åse Östholm Balkhed

Linköping University

17

Papers

369

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial.

2021 Trials
Show All
- Source
- Cite
- Save
Citations (4)
Prehospital delay is an important risk factor for mortality in community-acquired bloodstream infection (CA-BSI): a matched case-control study.

2021 BMJ Open
Show All
- Source
- Cite
- Save
Citations (0)
Rehabilitation Needs Following COVID-19: Five-Month Post-Discharge Clinical Follow-Up of Individuals With Concerning Self-Reported Symptoms

2021 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)
The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden.

2021 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Low incidence of antibiotic-resistant bacteria in south-east Sweden: An epidemiologic study on 9268 cases of bloodstream infection.

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (5)
Delay of appropriate antibiotic treatment is associated with high mortality in patients with community-onset sepsis in a Swedish setting

2019 European Journal of Clinical Microbiology & Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (16)
Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study

2018 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (18)
14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality

2016 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (25)
High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden

2013 Scandinavian Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (22)
In vitro susceptibility of CTX-M-producing Escherichia coli to non-beta-lactam agents

2012
Show All
- Source
- Cite
- Save
Citations (0)